Condition
Saphenous Vein
Total Trials
6
Recruiting
2
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 3 (1)
Trial Status
Recruiting2
Not Yet Recruiting1
Unknown1
Completed1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06981390Not ApplicableNot Yet Recruiting
Ticagrelor-Based Dual Antiplatelet Therapy Duration in CABG
NCT06603961Not ApplicableRecruiting
Prevention of Edema After Coronary Artery Bypass Graft by Customized Pressure-guided Elastic Bandages
NCT06787651Not ApplicableActive Not Recruiting
Comparison of RIMA-SVG and Ao-SVG Techniques in Coronary Artery Bypass Grafting
NCT05096351Recruiting
Immunological Reaction of the Recipient After Cold-stored Saphenous Venous Allograft (Bioprotec)
NCT03999398Unknown
Short and Long-term Results of PCI in no Touch Vein-graft.
NCT00348764Phase 3Completed
ESGVS: Sclerotherapy With Lauromacrogol
Showing all 6 trials